207 related articles for article (PubMed ID: 9480916)
1. High-efficiency expression and characterization of the synaptic-vesicle monoamine transporter from baculovirus-infected insect cells.
Sievert MK; Thiriot DS; Edwards RH; Ruoho AE
Biochem J; 1998 Mar; 330 ( Pt 2)(Pt 2):959-66. PubMed ID: 9480916
[TBL] [Abstract][Full Text] [Related]
2. Peptide mapping of the [125I]Iodoazidoketanserin and [125I]2-N-[(3'-iodo-4'-azidophenyl)propionyl]tetrabenazine binding sites for the synaptic vesicle monoamine transporter.
Sievert MK; Ruoho AE
J Biol Chem; 1997 Oct; 272(41):26049-55. PubMed ID: 9325342
[TBL] [Abstract][Full Text] [Related]
3. Photoaffinity labeling of the monoamine transporter of bovine chromaffin granules and other monoamine storage vesicles using 7-azido-8-[125I]iodoketanserin.
Isambert MF; Gasnier B; Laduron PM; Henry JP
Biochemistry; 1989 Mar; 28(5):2265-70. PubMed ID: 2719952
[TBL] [Abstract][Full Text] [Related]
4. Lobeline displaces [3H]dihydrotetrabenazine binding and releases [3H]dopamine from rat striatal synaptic vesicles: comparison with d-amphetamine.
Teng L; Crooks PA; Dwoskin LP
J Neurochem; 1998 Jul; 71(1):258-65. PubMed ID: 9648873
[TBL] [Abstract][Full Text] [Related]
5. Characterization of high-affinity [3H]TBZOH binding to the human platelet vesicular monoamine transporter.
Zucker M; Weizman A; Rehavi M
Life Sci; 2001 Sep; 69(19):2311-7. PubMed ID: 11669473
[TBL] [Abstract][Full Text] [Related]
6. The photoactivatable inhibitor 7-azido-8-iodoketanserin labels the N terminus of the vesicular monoamine transporter from bovine chromaffin granules.
Sagné C; Isambert MF; Vandekerckhove J; Henry JP; Gasnier B
Biochemistry; 1997 Mar; 36(11):3345-52. PubMed ID: 9116013
[TBL] [Abstract][Full Text] [Related]
7. Identification of the substrate binding region of vesicular monoamine transporter-2 (VMAT-2) using iodoaminoflisopolol as a novel photoprobe.
Gopalakrishnan A; Sievert M; Ruoho AE
Mol Pharmacol; 2007 Dec; 72(6):1567-75. PubMed ID: 17766642
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo studies of benzisoquinoline ligands for the brain synaptic vesicle monoamine transporter.
Lee LC; Vander Borght T; Sherman PS; Frey KA; Kilbourn MR
J Med Chem; 1996 Jan; 39(1):191-6. PubMed ID: 8568807
[TBL] [Abstract][Full Text] [Related]
9. Effects of nerve growth factor on dihydrotetrabenazine binding to PC12 cells.
Adamson CR; Emley TE; Herbig LJ; Near JA
Neurochem Int; 1997; 30(4-5):411-5. PubMed ID: 9106255
[TBL] [Abstract][Full Text] [Related]
10. Cloning and functional expression of a tetrabenazine sensitive vesicular monoamine transporter from bovine chromaffin granules.
Howell M; Shirvan A; Stern-Bach Y; Steiner-Mordoch S; Strasser JE; Dean GE; Schuldiner S
FEBS Lett; 1994 Jan; 338(1):16-22. PubMed ID: 8307150
[TBL] [Abstract][Full Text] [Related]
11. Expression cloning of a reserpine-sensitive vesicular monoamine transporter.
Erickson JD; Eiden LE; Hoffman BJ
Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10993-7. PubMed ID: 1438304
[TBL] [Abstract][Full Text] [Related]
12. Specific derivatization of the vesicle monoamine transporter with novel carrier-free radioiodinated reserpine and tetrabenazine photoaffinity labels.
Sievert MK; Hajipour AR; Ruoho AE
Anal Biochem; 2007 Aug; 367(1):68-78. PubMed ID: 17559790
[TBL] [Abstract][Full Text] [Related]
13. Binding of alpha-dihydrotetrabenazine to the vesicular monoamine transporter is stereospecific.
Kilbourn M; Lee L; Vander Borght T; Jewett D; Frey K
Eur J Pharmacol; 1995 May; 278(3):249-52. PubMed ID: 7589162
[TBL] [Abstract][Full Text] [Related]
14. Autoradiographic distribution of the eye monoaminergic synaptic vesicles.
Denis P; Nordmann JP; Scherman D; Saraux H; Rostène W
Ophthalmic Res; 1994; 26(4):232-9. PubMed ID: 7808734
[TBL] [Abstract][Full Text] [Related]
15. Mutagenesis and derivatization of human vesicle monoamine transporter 2 (VMAT2) cysteines identifies transporter domains involved in tetrabenazine binding and substrate transport.
Thiriot DS; Ruoho AE
J Biol Chem; 2001 Jul; 276(29):27304-15. PubMed ID: 11375404
[TBL] [Abstract][Full Text] [Related]
16. Regulation of rat brain vesicular monoamine transporter by chronic treatment with ovarian hormones.
Rehavi M; Goldin M; Roz N; Weizman A
Brain Res Mol Brain Res; 1998 Jun; 57(1):31-7. PubMed ID: 9630494
[TBL] [Abstract][Full Text] [Related]
17. Reduced striatal vesicular monoamine transporters after neurotoxic but not after behaviorally-sensitizing doses of methamphetamine.
Frey K; Kilbourn M; Robinson T
Eur J Pharmacol; 1997 Sep; 334(2-3):273-9. PubMed ID: 9369358
[TBL] [Abstract][Full Text] [Related]
18. Electrochemical monitoring of transport by a vesicular monoamine transporter expressed in Xenopus oocytes.
Whitley J; Parsons J; Freeman J; Liu Y; Edwards RH; Near JA
J Neurosci Methods; 2004 Feb; 133(1-2):191-9. PubMed ID: 14757360
[TBL] [Abstract][Full Text] [Related]
19. Ketanserin binds to the monoamine transporter of chromaffin granules and of synaptic vesicles.
Darchen F; Scherman D; Laduron PM; Henry JP
Mol Pharmacol; 1988 Jun; 33(6):672-7. PubMed ID: 3380081
[TBL] [Abstract][Full Text] [Related]
20. Decreased limbic vesicular monoamine transporter 2 in a genetic rat model of depression.
Schwartz K; Yadid G; Weizman A; Rehavi M
Brain Res; 2003 Mar; 965(1-2):174-9. PubMed ID: 12591135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
